Medullary thyroid carcinoma: management of lymph node metastases.
Medullary thyroid carcinoma (MTC) is a neuroendocrine malignancy of the thyroid C cells. Metastatic spread commonly occurs to cervical and mediastinal lymph nodes. MTC cells do not concentrate radioactive iodine and are not sensitive to hormonal manipulation. Surgery is currently the only therapy that can reliably lead to cure, reduction in tumor burden, or effective palliation. In patients with hereditary MTC, central lymph node dissection should be considered in preventative operations if the calcitonin level is elevated. Systematic surgical removal of at-risk or involved lymph node basins (compartmental dissection) should be performed in all patients with palpable primary tumors and recurrent disease. A "berry-picking" approach is discouraged. Although data are limited, standard chemotherapy and radiation therapy have not been shown to be effective in the treatment of MTC. Newer targeted drug therapies are promising and are being examined in therapeutic clinical trials.
Moley
Jeffrey F
JF
Department of Surgery, Endocrine and Oncologic Surgery Section, Siteman Cancer Center, Washington University School of Medicine, and St. Louis Veteran's Affairs Medical Center, St. Louis, Missouri 63110, USA. moleyj@wustl.edu
D018276:Carcinoma, Medullary / Q000000981:diagnostic imaging / Q000556:secondary* / Q000601:surgery*; D006801:Humans; D008197:Lymph Node Excision; D008198:Lymph Nodes / Q000473:pathology*; D008207:Lymphatic Metastasis; D019106:Postoperative Hemorrhage; D011877:Radionuclide Imaging; D012086:Reoperation; D013964:Thyroid Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery*; D013965:Thyroidectomy